There's No Single Cause Behind The Overdose Epidemic

There’s a reason you see and hear so much about fentanyl; its potency as an opioid is surpassed only by its ability to damage public health when illicitly manufactured, distributed and misused. But, with stories of fentanyl-fueled tragedy dominating the news, it’s easy to overlook the fact that our nation’s health faces a significant threat from another, very close-at-hand source -- the diversion of drugs stored at home. A look at available data, however, reveals how “loss of custody” of medications at the household level is contributing to the current health emergency.

• Read more about There's No Single Cause Behind The Overdose Epidemic

Leveraging Returns And Sustainability To Improve The Customer Experience

E-commerce continues to present merchants with new challenges and opportunities. Understanding the best way to address these challenges will boost shopper loyalty, increase customer lifetime value, and make your operations more sustainable. Recognizing – and addressing – the everchanging needs of the e-commerce buyer is an ongoing practice. Emerging technologies and shifting consumer behaviors require digital sellers to make continuous improvements, particularly in the areas of:

• Read more about Leveraging Returns And Sustainability To Improve The Customer Experience

Inmar Intelligence Hosts 8th Medication Disposal Drive-Thru Event on April 27th

Safely dispose of unused or expired medications at Bolton Elementary School in Winston-Salem.

• Read more about Inmar Intelligence Hosts 8th Medication Disposal Drive-Thru Event on April 27th

Transforming Drug Diversion Monitoring with AI

Drug diversion monitoring plays a critical role in maintaining the integrity of pharmaceutical supply chains, helping ensure patient safety and preventing illicit activities. It’s worth noting that approximately 1 in every 100 healthcare workers are estimated to divert drugs (Protenus, 2023 Diversion Digest). Relying solely on manual processes to detect anomalies and identify trends that point to drug diversion in the clinical space has proven to be time-consuming, error-prone, and costly. Enter AI — a game-changer that has revolutionized drug diversion monitoring with efficient pattern recognition, real-time insights, and enhanced accuracy.

• Read more about Transforming Drug Diversion Monitoring with AI

Manufacturer CMOs Reevaluate Retail Media Network Investments

Inmar Intelligence Research Reveals Future Outlook of the State of Retail Media Networks

• Read more about Manufacturer CMOs Reevaluate Retail Media Network Investments

Successful Returns Management Starts With An Effective Returns Policy

Establishing a clear and consistent returns policy is an absolute requirement for any drug- or device-maker committed to successfully mitigating the financial liability attached to product flowing back through the supply chain.

• Read more about Successful Returns Management Starts With An Effective Returns Policy

US Department of Health and Human Services Selects Inmar Intelligence for a 5-year Contract to Deliver Pharmaceutical Supply Chain Solutions

Inmar Intelligence, a leading provider of data-driven healthcare technology solutions, today announced it has secured a contract with the US Department of Health and Human Services (HHS) to provide pharmaceutical supply chain solutions across the country.

• Read more about US Department of Health and Human Services Selects Inmar Intelligence for a 5-year Contract to Deliver Pharmaceutical Supply Chain Solutions

Importing Drugs from Canada: Prudent policy or political ploy?

The recent decision by the Food and Drug Administration to approve Florida’s Canadian Prescription Drug Importation Program was definitely a new development in the “Will Canadian drug imports solve anything?” saga, but that the FDA gave the state the go-ahead should be no real surprise to anyone.

• Read more about Importing Drugs from Canada: Prudent policy or political ploy?

Did This Season’s Inflation Issue End the Online Shopping Boom?

Inflation was the topic on everyone’s lips in the lead-up to holiday shopping — not exactly the most festive way to open the season. This atmosphere resulted in fairly lackluster predictions for sales, and although it’s been on a steady upward swing since the pandemic, e-commerce was very much included in that forecast.

• Read more about Did This Season’s Inflation Issue End the Online Shopping Boom?

The Push for Healthcare Price Transparency: Will Pharmacies See a Benefit?

Recent passage of the Lower Costs, More Transparency (LCMT) Act in a bipartisan vote by the U.S. House of Representatives is being heralded by the bill’s sponsors as “landmark legislation,” but is it really? The bill -- which is a long way from becoming law -- is focused on the very politically popular issue of lowering prescription drug prices for consumers. But where is the benefit for pharmacies?  

• Read more about The Push for Healthcare Price Transparency: Will Pharmacies See a Benefit?